Atlas Trials

UroGen Pharma Ltd.

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch UroGen Pharma Ltd.

RecordFirmDate
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer (NCT06774131)UroGen Pharma Ltd.2025-08-06
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (NCT06331299)UroGen Pharma Ltd.2024-08-29
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto (NCT05874921)UroGen Pharma Ltd.2023-11-17
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05375903)UroGen Pharma Ltd.2022-06-01
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (NCT05243550)UroGen Pharma Ltd.2022-03-01
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) (NCT05136898)UroGen Pharma Ltd.2021-11-30
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (NCT04688931)UroGen Pharma Ltd.2021-02-19
Efficacy and Safety of UGN-101 in Recurrent Patients (NCT04006691)UroGen Pharma Ltd.2019-10-01
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (NCT03558503)UroGen Pharma Ltd.2018-10-15

Track UroGen Pharma Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.